Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1054-1057

  Saito, Toshikazu ^a   Ishikawa, San E ^a   Abe, Keishi ^b   Kamoi, Kyuzi ^c   Yamada, Kenichi ^d   Shimizu, Kurakazu ^e   Saruta, Takao ^f   Yoshida, Sho ^g  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGAOKA RED CROSS HOSPITAL   (Japan)

^d SAKURA NATIONAL HOSPITAL   (Japan)

^e TOKYO ROSAI HOSPITAL   (Japan)

^f KEIO UNIVERSITY   (Japan)

^g CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; MOZAVAPTAN; VASOPRESSIN ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PLASMA OSMOLALITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; URINE VOLUME;

EID: 0031001022     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.4.3900     Document Type: Article

References (18)

1. Schwartz WB, Bennet W, Curelop S, Bartter FC. 1957 A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 23:529-542.
2. Bartter FC, Schwartz WB. 1967 The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790-806.
3. Cutting HO. 1971 Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am J Med. 51:269-271.
4. Cooke CR, Turin MD, Walker WG. 1979 The syndrome of inappropriate antidiuretic hormone secretion: pathophysiologic mechanisms in solute and volume regulation. Medicine. 58:240-251.
5. Hainsworth JD, Workman R, Greico A. 1983 Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer. 5:161-165.
6. Ishikawa S, Okada K, Saito T. 1994 Vasopressin secretion in health and disease. In: Imura H, ed. The Pituitary Gland, 2nd ed. New York; Raven Press: pp. 331-350.
7. Fujisawa G, Ishikawa S, Tsuboi Y, Okada K, Saito T. 1993 Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44:19-23.
8. 2 receptor antagonist. Br J Pharmacol. 105:787-791.
9. Tsuboi Y, Ishikawa S, Fujisawa G, Okada K, Saito T. 1994 Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Kidney Int. 46:237-244.
10. Tsuboi Y, Ishikawa S, Fujisawa G, Okada K, Saito T. 1994 In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats. J Endocrinol. 143:227-234.
11. Ohnishi A, Orita Y, Okahara R, et al. 1993 Potent aquaretic agent: a novel nonpeptide selective vasopressin antagonist (OPC-31260) in men. J Clin Invest. 92:2653-2659.
12. Ohnishi A, Orita Y, Takagi N, et al. 1995 Aquaretic effect of a potent orally active, nonpeptide V, antagonist in men. J Pharmacol Exp Ther. 272:546-551.
13. 2 antagonist OPC-31260 in hydropenic humans. Kidney Int. 48:220-226.
14. Ishikawa S, Fujita N, Fujisawa G, et al. 1996 Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatremia in elderly patients. Endocrinol JPN. 43:101-108.
15. 18 silica column. Folia Endocrinol JPN. 61:724-736.
16. Ishikawa S, Saito T, Okada K, Tsutsui K, Kuzuya T. 1986 Effect of vasopressin antagonist on water excretion in inferior vena cava constriction. Kidney Int 30:49-55.
17. Ishikawa S, Okada K, Saito T. 1992 Effect of new non-peptide arginine vasopressin (AVP) antagonists OPC-31260 and OPC-21268 on cellular action of AVP in cultured rat renal papillary collecting tubule cells. J Am Soc Nephrol. 3:794.
18. Fujita N, Ishikawa S, Sasaki S, et al. 1995 Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol. 269:F926-F931.